Clinical trials
Observational Coinfection trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2014 | 4 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 6 |
| Unknown status | 5 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| University of Florida | 3 |
| Bayside Health | 2 |
| Asan Medical Center | 1 |
| Astana Medical University | 1 |
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| Centre Hospitalier de Cayenne | 1 |
| Centre Hospitalier de Saint-Denis | 1 |
| Chinese University of Hong Kong | 1 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coinfection | 36 |
| Acquired Immunodeficiency Syndrome | 8 |
| COVID-19 | 7 |
| Hepatitis B | 7 |
| Hepatitis C | 7 |
| HIV Infections | 6 |
| Mycoses | 4 |
| Respiratory Tract Infections | 4 |
| Bacterial Infections | 3 |
| Pneumonia | 3 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.